Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clinically Significant Portal Hypertension”

30 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 30 results

Not applicableLooking for participantsNCT07111221
What this trial is testing

Portal Inflow Modulation Prior to Liver Transplantation in Patients With Increased Risk of Intraoperative Blood Loss

Who this might be right for
Liver CirrhosisClinically Significant Portal Hypertension
Medical University of Warsaw 104
Not applicableLooking for participantsNCT06513195
What this trial is testing

EUS-guided Response Assessment to NSBB

Who this might be right for
Portal Hypertension Related to Cirrhosis
Universitaire Ziekenhuizen KU Leuven 24
Not applicableNot Yet RecruitingNCT07797101
What this trial is testing

Body-weight Reduction Effect on Portal Hypertension in Compensated Cirrhosis

Who this might be right for
CirrhosisPortal HypertensionFatty Liver Disease+1 more
The Second Affiliated Hospital of Chongqing Medical University 50
Not applicableStudy completedNCT06145100
What this trial is testing

Prediction of Portal Hypertension in Patients With CVID (CVID-pHT)

Who this might be right for
Non-Cirrhotic Portal HypertensionCommon Variable Immunodeficiency
University Hospital Freiburg 250
Not applicableNot Yet RecruitingNCT07405749
What this trial is testing

Cirrhotic and Non-cirrhotic Patients With Clinically Significant Portal Hypertension

Who this might be right for
Cirrhosis, LiverPortal HypertensionClinically Significant Portal Hypertension(CSPH)+1 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 2,500
Not applicableStudy completedNCT06245798
What this trial is testing

Liver Resection for Patients With Hepatocellular Carcinoma and Clinically Significant Portal Hypertension

Who this might be right for
Hepatic Carcinoma
Tang-Du Hospital 3,000
Not applicableStudy completedNCT06015373
What this trial is testing

The Impact of Carvedilol Posology on Clinically Significant Portal Hypertension

Who this might be right for
Clinically Significant Portal Hypertension
Centro Hospitalar De São João, E.P.E. 34
Testing effectiveness (Phase 2)Ended earlyNCT05161481
What this trial is testing

Test Whether Two Different Doses of Avenciguat Help People With Liver Cirrhosis and High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver)

Who this might be right for
Hypertension, Portal
Boehringer Ingelheim 80
Not applicableStudy completedNCT03138915
What this trial is testing

Radiomics Signature of Hepatic Venous Pressure Gradient (rHVPG) With CT Angiography (CHESS1701)

Who this might be right for
Hypertension, Portal
Nanfang Hospital, Southern Medical University 385
Not applicableStudy completedNCT03436550
What this trial is testing

Assessment of Portal Hypertension With Multiparametric MRI

Who this might be right for
Portal HypertensionClinically Significant Portal Hypertension
Icahn School of Medicine at Mount Sinai 69
Not applicableLooking for participantsNCT06266260
What this trial is testing

Direct Portal Pressure Measurement Via Endoscopic Ultrasound in Advanced Chronic Liver Disease (EVADIPP)

Who this might be right for
Portal Hypertension
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 50
Not applicableStudy completedNCT07703540
What this trial is testing

Inferior Vena Cava Pressure as Alternative to Hepatic Venous Pressure for EUS-guided Portal Pressure Gradient Measurement

Who this might be right for
CirrhosisLiver Disease ChronicPortal Hypertension
University Hospital Muenster 40
Not applicableUnknownNCT01358123
What this trial is testing

Value of Von Willebrand Factor in Portal Hypertension

Who this might be right for
Liver CirrhosisPortal Hypertension
Medical University of Vienna 300
Testing effectiveness (Phase 2)Ended earlyNCT06082843
What this trial is testing

Test Whether Avenciguat Helps People With Liver Cirrhosis and High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver) Who Had Bleeding in the Esophagus or Fluid Accumulation in the Belly

Who this might be right for
Hypertension, PortalLiver Cirrhosis
Boehringer Ingelheim 22
Not applicableStudy completedNCT02842697
What this trial is testing

Virtual Hepatic Venous Pressure Gradient (vHVPG) With CT Angiography (CHESS1601)

Who this might be right for
Hypertension, Portal
Nanfang Hospital, Southern Medical University 102
Not applicableStudy completedNCT02439567
What this trial is testing

Transient Elastography to Assess Liver Fibrosis and Portal Hypertension in HCV Cirrhotic Patients Treated With New Antiviral Drugs (SPLEEN-C)

Who this might be right for
Chronic Hepatitis CCirrhosisPortal Hypertension
Hospital Universitari Vall d'Hebron Research Institute 41
Not applicableStudy completedNCT05767229
What this trial is testing

Acute Hemodynamic Response to Carvedilol in Children With Clinically Significant Portal Hypertension.

Who this might be right for
Portal Hypertension
Institute of Liver and Biliary Sciences, India 40
Testing effectiveness (Phase 2)Study completedNCT01714609
What this trial is testing

The Effect of Sorafenib on Portal Pressure

Who this might be right for
Clinically Significant Portal Hypertension
Yale University 10
Not applicableUnknownNCT01860222
What this trial is testing

Surgical Resection Versus Percutaneous Local Ablative Therapy for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma With CSPH
Eastern Hepatobiliary Surgery Hospital 160
Large-scale testing (Phase 3)Not Yet RecruitingNCT06263816
What this trial is testing

Effect of Long-term Carvedilol to Prevent Decompensation or Death in Patients With Asymptomatic Child-Pugh A5 to B8 Cirrhosis and Clinically Significant Portal Hypertension: a Multicenter Double-blind Randomized Control Trial

Who this might be right for
Asymptomatic CirrhosisClinically Significant Portal Hypertension
University Hospital, Tours 290
Next Page